Skip to main content
VIVS
NASDAQ Life Sciences

VivoSim Signs Seven-Figure Pharma Deal, Sees FY2027 Growth Above 500%

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.154
Mkt Cap
$2.434M
52W Low
$0.118
52W High
$3.4
52W Position info
30% above low
Off High info
95% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

VIVS sits 30% above its 52-week low of $0.118 on light trading volume (0.3× avg).

Summary

VivoSim signed a seven-figure paid program-work agreement with a top-10 global pharmaceutical company, converting a large customer from evaluation to paid work, and the stock surged 82% premarket on the news. Management also said fiscal 2027 revenue growth should exceed its prior 500%+ guidance, though it gave no revised percentage or prior-period revenue comparison. Both toxicology service lines grew in the September quarter, but no rates or revenue figures were disclosed. The contract value is undisclosed, so revenue visibility stays thin — this is a micro-cap that just posted its first service revenue of $22K in fiscal Q2 with $8.6M of cash and going-concern doubt, and it still faces a Nasdaq $1 minimum bid compliance issue plus an approved reverse split. The deal is a real commercial step, but the size of the contribution is what determines whether it matters.

At the time of this announcement, VIVS was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.12 to $3.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

VIVS - Latest Insights

VIVS
Nov 12, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1342
Real-time Price: $0.3587 info
Change: +$0.2245 (+167%) info
Market Cap: $2.434M info
VIVS
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.2019
Real-time Price: $0.3587 info
Change: +$0.1568 (+78%) info
Market Cap: $2.434M info
VIVS
Sep 16, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3067
Real-time Price: $0.3587 info
Change: +$0.052 (+17%) info
Market Cap: $2.434M info
VIVS
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.286
Real-time Price: $0.3587 info
Change: +$0.0727 (+25%) info
Market Cap: $2.434M info
VIVS
Aug 21, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.286
Real-time Price: $0.3587 info
Change: +$0.0727 (+25%) info
Market Cap: $2.434M info